Learn About Sclerosing Cholangitis

What is the definition of Sclerosing Cholangitis?

Sclerosing cholangitis refers to swelling (inflammation), scarring, and destruction of the bile ducts inside and outside of the liver.

What are the alternative names for Sclerosing Cholangitis?

Primary sclerosing cholangitis; PSC

What are the causes of Sclerosing Cholangitis?

The cause of this condition is unknown in most cases.

The disease may be seen in people who have:

  • Inflammatory bowel disease (IBD) such as ulcerative colitis and Crohn disease
  • Autoimmune disorders
  • Chronic pancreatitis (inflamed pancreas)
  • Sarcoidosis (a disease that causes inflammation in various parts of the body)

Genetic factors may also be responsible. Sclerosing cholangitis occurs more often in men than women. This disorder is rare in children.

Sclerosing cholangitis may also be caused by:

  • Choledocholithiasis (gallstones in the bile duct)
  • Infections in the liver, gallbladder, and bile ducts
What are the symptoms of Sclerosing Cholangitis?

The first symptoms are usually:

  • Fatigue
  • Itching
  • Yellowing of the skin and eyes (jaundice)

However, some people have no symptoms.

Other symptoms may include:

  • Enlarged liver
  • Enlarged spleen
  • Loss of appetite and weight loss
  • Repeat episodes of cholangitis (an infection of the bile duct that causes fever, jaundice and pain in the right upper abdomen)
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Sclerosing Cholangitis?

Medicines that may be used include:

  • Cholestyramine (such as Prevalite) to treat itching
  • Ursodeoxycholic acid (ursodiol) to improve liver function
  • Fat-soluble vitamins (D, E, A, K) to replace what is lost from the disease itself
  • Antibiotics to treat infections in the bile ducts

These surgical procedures may be done:

  • Inserting a long, thin tube with a balloon at the end to open up narrowing (endoscopic balloon dilation of strictures)
  • Placement of a drain or tube for major narrowing (strictures) of bile ducts
  • Proctocolectomy (removal of colon and rectum, for those who have both ulcerative colitis and sclerosing cholangitis) does not affect the progression of primary sclerosing cholangitis (PSC)
  • Liver transplant
Who are the top Sclerosing Cholangitis Local Doctors?
Andrew J. Muir
Elite in Sclerosing Cholangitis
Gastroenterology
Elite in Sclerosing Cholangitis
Gastroenterology

Duke Health Integrated Practice Inc

2301 Erwin Rd, 
Durham, NC 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Andrew Muir is a Gastroenterologist in Durham, North Carolina. Dr. Muir and is rated as an Elite provider by MediFind in the treatment of Sclerosing Cholangitis. His top areas of expertise are Hepatitis C, Sclerosing Cholangitis, Hepatitis, Liver Transplant, and Kidney Transplant. Dr. Muir is currently accepting new patients.

Bo C. Shen
Elite in Sclerosing Cholangitis
Gastroenterology
Elite in Sclerosing Cholangitis
Gastroenterology

Trustees Of Columbia University In The City Of New York

622 W 168th St, 
New York, NY 
Experience:
43+ years
Languages Spoken:
English
Offers Telehealth

Bo Shen is a Gastroenterologist in New York, New York. Dr. Shen has been practicing medicine for over 43 years and is rated as an Elite provider by MediFind in the treatment of Sclerosing Cholangitis. His top areas of expertise are Crohn's Disease, Viral Gastroenteritis, Colitis, Ileostomy, and Endoscopy.

 
 
 
 
Learn about our expert tiers
Learn More
Tom H. Karlsen
Elite in Sclerosing Cholangitis
Elite in Sclerosing Cholangitis
Oslo, NO 

Tom Karlsen practices in Oslo, Norway. Mr. Karlsen and is rated as an Elite expert by MediFind in the treatment of Sclerosing Cholangitis. His top areas of expertise are Sclerosing Cholangitis, Cholangitis, Cholangiocarcinoma (Bile Duct Cancer), Liver Transplant, and Endoscopy.

What is the outlook (prognosis) for Sclerosing Cholangitis?

How well people do varies. The disease tends to get worse over time. Sometimes people develop:

  • Ascites (buildup of fluid in the space between the lining of the abdomen and abdominal organs) and varices in the esophagus or stomach (enlarged veins)
  • Biliary cirrhosis (liver scarring due to inflammation of the bile ducts)
  • Liver failure
  • Persistent jaundice

Some people develop infections of the bile ducts that keep returning.

People with this condition have a high risk for developing cancer of the bile ducts (cholangiocarcinoma). They should be checked regularly with a liver imaging test and blood tests. People who also have IBD may have an increased risk for developing cancer of the colon or rectum and should have periodic colonoscopy.

What are the possible complications of Sclerosing Cholangitis?

Complications may include:

  • Bleeding esophageal varices
  • Cancer in the bile ducts (cholangiocarcinoma)
  • Cirrhosis and liver failure
  • Infection of the biliary system (cholangitis)
  • Narrowing of the bile ducts
  • Vitamin deficiencies
What are the latest Sclerosing Cholangitis Clinical Trials?
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis

Summary: The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Sclerosing Cholangitis (PSC), and to assess the possible impact on the disease progression of PSC.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Peroxisome Proliferator-Activated Receptor Agonists to Prevent Primary Sclerosing Cholangitis Recurrence After Liver Transplantation

Summary: This study aims to determine the efficacy of 36 months once-daily fenofibrate in preventing clinically-detectable recurrence of primary sclerosing cholangitis after liver transplantation, compared with a historical control cohort that was not treated with

Who are the sources who wrote this article ?

Published Date: May 02, 2023
Published By: Michael M. Phillips, MD, Emeritus Professor of Medicine, The George Washington University School of Medicine, Washington, DC. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Ahrendt GM, Ahrendt SA. Gallbladder and biliary tree: Management of primary sclerosing cholangitis. In: Cameron AM, Cameron JL, eds. Current Surgical Therapy. 14th ed. Philadelphia, PA: Elsevier; 2023:457-538.

Bowlus C, Assis DN, Goldberg D. Primary and secondary sclerosing cholangitis. In: Sanyal AJ, Boyer TD, Lindor KD, Terrault NA, eds. Zakim and Boyer's Hepatology. 7th ed. Philadelphia, PA: Elsevier; 2018:chap 43.

Levy C, Bowlus CL. Primary and secondary sclerosing cholangitis. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management. 11th ed. Philadelphia, PA: Elsevier; 2021:chap 68.